Zelia Maria Correa, MD, PhD

Audina Berrocal, MD, is a pediatric retina specialist and world-leader in the medical and surgical management of retinopathy of prematurity and pediatric vitreoretinal disorders. Berrocal has been instrumental in the description and management of pediatric retinal disorders. She has advanced the use of fluorescein angiography in pediatric vitreoretinal disorders improving outcomes. She has also taken care of an inner-city neonatal Intensive Care Unit weekly for the past 20 years preventing blindness among the premature. Furthermore, she has been the first surgeon to treat the youngest patient in the United States with the first FDA-approved gene therapy.

Janet L Davis, MD, M.B.A., is an internationally recognized expert in uveitis as well as a medical retina and vitreoretinal specialist. Her expertise includes infectious and inflammatory diseases of the eye with an emphasis on diagnostic procedures and clinical management of uveitis. She is active in the diagnosis of primary vitreoretinal lymphoma utilizing flow cytometry and gene rearrangement combined with cytology. She has participated in numerous clinical trials in uveitis throughout her career, including surgical implantation of drug delivery devices.